Evidence map›Paper›PMID 38677336›Full record

ArticleJournal of the American Academy of Dermatology2024

Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.

Upeka Samarakoon, Anna R Wolfson, Li Zhou, Fatima Bassir, Elizabeth Phillips, Daniela Kroshinsky, Bethany Cucka, Bianca Biglione, Neelam A Phadke, Jordon Jaggers and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Upeka SamarakoonDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Anna R WolfsonDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Li ZhouHarvard Medical School, Boston, Massachusetts; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Fatima BassirDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Elizabeth PhillipsDepartment of Medicine, Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
Daniela KroshinskyDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Bethany CuckaDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Bianca BiglioneDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Neelam A PhadkeDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Jordon JaggersDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Emily C ByrneDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Allen D JuddDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Kimberly G BlumenthalDivision of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: kblumenthal@mgh.harvard.edu.

Funding

Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug ReactionsR01AI150295 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2019 to 2022
$2.8M
Encoding and Processing Patient Allergy Information in EHRsR01HS022728 · AHRQ · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2013 to 2016
$2.0M
Improving Allergy Documentation and Clinical Decision Support in the EHRR01HS025375 · AHRQ · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2018 to 2021
$1.6M
AHRQ HHS R01 HS022728AHRQ HHS R01 HS025375NIAID NIH HHS R01 AI150295
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Hypersensitivity SyndromeQualitative ResearchAdultAgedEosinophiliaFemaleHumansMaleMiddle Agedantiepileptic hypersensitivity syndromedrug allergydrug-induced hypersensitivity syndromehypersensitivitypatient-reported outcomesSCARsevere cutaneous adverse reaction

Identifiers

PMID38677336
PMCPMC11267464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.